Aug 8
|
Q2 2023 INmune Bio Inc Earnings Call
|
Aug 7
|
INmune Bio Inc. Announces Second Quarter 2023 Results and Provides Business Update
|
May 24
|
INmune Bio Inc.’s Chief Scientific Officer, Mark Lowdell, Ph.D. to Present Plenary Talk at International Society of Cell & Gene Therapy
|